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Abstract
Background: High rates of preterm births remain a UK public health concern. Preterm birth is a major determinant
of adverse infant and longer-term outcomes, including survival, quality of life, psychosocial effects on the family
and health care costs. We aim to test whether a model of care combining continuity of midwife care with rapid
referral to a specialist obstetric clinic throughout pregnancy, intrapartum and the postpartum period is feasible and
improves experience and outcomes for women at increased risk of preterm birth.
Methods: This pilot, hybrid, type 2 randomised controlled implementation trial will recruit 350 pregnant women at
increased risk of preterm birth to a midwifery continuity of care intervention or standard care. The intervention will be
provided from recruitment (antenatal), labour, birth and the postnatal period, in hospital and community settings and
in collaboration with specialist obstetric clinic care, when required. Standard care will be the current maternity care
provision by NHS midwives and obstetricians at the study site. Participants will be followed up until 6–8 weeks
postpartum. The composite primary outcome is the appropriate initiation of any specified interventions related to the
prevention and/or management of preterm labour and birth. Secondary outcomes are related to: recruitment and
attrition rates; implementation; acceptability to women, health care professionals and stakeholders; health in pregnancy
and other complications; intrapartum outcomes; maternal and neonatal postnatal outcomes; psycho-social health;
quality of care; women’s experiences and health economic analysis. The trial has 80% power to detect a 15% increase
in the rate of appropriate interventions (40 to 55%). The analysis will be by ‘intention to treat’ analysis.
Discussion: Little is known about the underlying reasons why and how models of midwifery continuity of care are
associated with fewer preterm births, better maternal and infant outcomes and more positive experiences; nor how
these models of care can be implemented successfully in the health services. This will be the first study to provide
direct evidence regarding the effectiveness, implementation and evaluation of a midwifery continuity of care model
and rapid access to specialist obstetric services for women at increased risk of preterm birth.
Trial registration: ISRCTN37733900. Retrospectively registered on 21 August 2017.
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Background
Preterm birth (PTB) is a birth that occurs at < 37 weeks of
gestation. PTB rates are increasing worldwide, despite ad-
vances in antenatal care [1]. The cost of PTB to the UK
National Health Service (NHS) is estimated to exceed £3
billion per annum [2]. PTB is associated with poorer qual-
ity of life [3], with no single strategy effective in reducing
rates [4]. There are multiple known risk factors associated
with early birth including previous PTB, late miscarriage
and cervical surgery, but the cause of spontaneous PTB is
unknown in approximately 40–50% of cases [5].
A Cochrane review of 15 trials involving 17,674 women
reported that women randomised to receive continuity of
care by one named midwife, or a small group of midwives,
during pregnancy, birth and the postnatal period were sig-
nificantly more likely to be attended at birth by a known
midwife. They were significantly less likely to experience
PTB or fetal loss/neonatal death before 24 weeks and had
fewer fetal/neonatal deaths in total [6]. There is also evi-
dence of increased referral to specialist services and clinical
benefit for women with social complexity [7].
Screening and managing women at increased risk of
PTB in specialist obstetric clinics is now considered use-
ful [8]. However, PTB clinics or preterm surveillance
clinics are rarely available outside research settings, and
women who require specialist medical and obstetric
expertise often receive fragmented midwifery care.
Continuity of carer is identified in the current maternity
policy document ‘Better Births’ as a model of care that
the NHS England is committed to increase. However,
around 75% of women have not met the midwife who
attends their birth beforehand [9]. Our research [10–12]
provides a basis to develop and test the impact of a
novel care pathway for women at increased risk of PTB,
which combines continuity of midwife care with rapid
referral to a specialist obstetric clinic throughout
pregnancy through to the intrapartum and postpartum
periods [13].
POPPIE (Pilot study Of midwifery Practice in Preterm
birth Including women’s Experiences) is a pilot, hybrid, type
2 randomised controlled implementation trial to determine
whether this model of continuity of care is feasible, and
could improve pregnancy outcomes and women’s experi-
ences. The setting will be an inner-city hospital in South
London.
The TIDieR guidance [14] will be used to describe the
intervention and standard care. In order to clarify assump-
tions in relation to how the intervention will be imple-
mented, and the mechanisms through which it will
produce change in this context, a logic model informs data
items for the implementation outcomes assessment [15]
(Fig. 1). We will use the Reach Effectiveness Adoption Im-
plementation Maintenance (RE-AIM) [16] and Medical Re-
search Council (MRC) [17] guidance for the evaluation of
complex interventions to assess feasibility, acceptability to
staff and women, adoption, fidelity, reach, equity, penetra-
tion, costs and sustainability, and to inform implementation
and the mechanisms of impact on maternal and neonatal
health, women’s experiences of care and quality of care.
How the intervention may work?
Continuity of care is defined as delivering care that
acknowledges that a woman’s health needs are related to
events and should be managed over time [6]. Therefore,
midwifery continuity of care allows women to develop a
relationship with the same caregivers throughout
pregnancy, birth and the postnatal period. Women have
a named and a ‘backup’ midwife, from the same team,
Fig. 1 POPPIE logic model for research
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caring for them during labour, birth and the postpartum
period, whom they have met before and feel they know.
This trusting relationship may increase their confidence
and reduce levels of psychosocial stress [18, 19]. This
close relationship between women and midwives may
also help women feel that they have a health care
provider who knows their medical history who will be
caring for them throughout labour, birth and the postna-
tal period [20, 21]. The trust and feeling of safety that
this may afford may mean that women are more willing
to accept help from psychiatric services, domestic
violence advocacy and other services, where required.
Women may be more likely to talk about lifestyle
choices, such as smoking and drinking, and to trust the
advice they receive [7, 22]. However, women may also be
unhappy with a perceived intrusive surveillance.
It is also hypothesised that there is an improved
co-ordination and collaboration between midwives work-
ing in continuity models of care and the multi-disciplinary
network of support, improved access to care, improved
care according to guidelines, earlier recognition of prob-
lems and improved health behaviours. Thus, the initiation
of treatments to prevent or reduce PTB may occur earlier
in the intervention group because the midwives have
greater knowledge, there are lower barriers for women to
contact midwives and faster access to obstetric opinion
and management.
Methods
The aim of this study is to test in a pilot study if a model
of care combining continuity of midwife care with rapid
referral to a specialist obstetric clinic for women at in-
creased risk of PTB is feasible and improves experience,
pregnancy outcomes and quality of care. If feasibility is
confirmed, learning from this pilot trial will inform a
full-scale multi-centre trial, following the MRC guide-
lines [17] – aimed at improving outcomes and reducing
the incidence and appropriate and timely management
of PTB.
Design, setting and population
We will undertake a two-armed, parallel-design, indi-
vidually pilot randomised controlled trial. A type 2
hybrid design will place equal focus on evaluating the
effectiveness of the intervention and the implementa-
tion [23]. The study will be undertaken in an
inner-city hospital in South London with a higher
than national average PTB rate (8.2 vs 7.2% in Eng-
land) [24]. The study population will include pregnant
women booking for antenatal care, identified as at
increased risk of PTB and residing in the hospital
catchment area in the study period (Fig. 2).
Participants
We will include asymptomatic pregnant women with
singleton pregnancies attending for antenatal care at
less than 24 weeks’ gestation and identified at in-
creased risk of PTB – fulfilling one or more of the
following criteria: previous cervical surgery (such as
cone biopsy, loop diathermy); uterine abnormality
(such as bicornuate uterus); previous short cervix or
short cervix this pregnancy (< 25 mm); previous cerc-
lage; previous premature ruptured membranes (< 37
weeks); one or more previous PTB (< 37 weeks); one
or more previous late miscarriage/abortion (> 14
weeks); current smoker of tobacco, as identified at
first antenatal appointment. We will exclude women
aged < 18 years at recruitment, multiple pregnancies,
unable/unwilling to give informed consent and those
already receiving care from a specialist midwifery
team (e.g. women with severe mental illness, diabetes,
alcohol and substance misuse).
Fig. 2 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) adapted for the POPPIE trial
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Identification, screening, recruitment and randomisation
Trial information will be available in all relevant clinical
areas including maternity services, general practice sur-
geries and health centres. Community midwives and
other maternity care clinicians will refer women who ex-
press an interest in the study to the midwifery team
leader to discuss trial participation. At early nuchal and/
or anomaly ultrasound scan appointments, women who
meet inclusion criteria will be offered verbal and written
information about the study. Potentially eligible women
will also be identified by review of medical records and ap-
pointment lists by clinical staff. In these cases, women will
be contacted by a member of the direct clinical team to
discuss their eligibility and study participation and sent a
leaflet by post/email to read (if interested) before their
appointment attendance. Adequate time will be given to
interested women to explain the study, for considering
participation, and asking any questions with members of
the clinical team. All participants will provide written
informed consent prior to participation.
Baseline data will be collected, and participants
randomised in a 1:1 ratio to receive either POPPIE
care or routine standard care. Randomisation will be
managed via a secure web-based randomisation
system (MedSciNet™), which is part of a password-
protected Internet-based study specific data manage-
ment system. A minimisation algorithm will be used
to ensure balance between the groups with respect
to smoking at booking and previous PTB (< 37
weeks). The nature of the intervention is such that
blinding of participants and care providers cannot be
achieved. However, risk of bias will be reduced since
data will be processed by researchers blinded to the
model of care that the women is allocated to. The
flow diagram of participants though the study is
shown in Fig. 3.
Intervention: POPPIE midwifery team
Women allocated to the intervention group will re-
ceive a continuity of midwife care model during the
antenatal, labour, birth and postnatal periods, pre-
dominantly from one midwife and her partner mid-
wife (backed up by the rest of the POPPIE team).
Midwives will ‘follow women’ and scheduled and out
of hours’ antenatal, intrapartum and postnatal care
may be provided in hospital, community/children’s
centres or at home. Midwives will provide continuity
of care in a multi-disciplinary network of consultation
and referral with other care providers. Some antenatal
and/or intrapartum and/or postpartum care will be pro-
vided in consultation with medical staff, as appropriate
[5]. Within this model, midwives work in partnership with
the woman; they are the primary professional with respon-
sibility for assessment of needs, planning care, referral to
other professionals as appropriate, and for ensuring
co-ordination of services. Clinical care content will follow
NHS Trust hospital guidelines. The team will have rapid
access using a mobile phone to a linked consultant obstet-
rician with specialist expertise in PTB to refer and/or dis-
cuss any clinical concerns, issues or queries.
The POPPIE team will include six Whole-time Equiva-
lent (WTE) midwives, including an experienced senior
midwife who leads the team. Specialist training (preventing
and managing PTB; caring for preterm infants; bereave-
ment; working in midwifery continuity of care models),
research training (Good Clinical Practice); valid informed
consent; data collection and data entry) and ongoing sup-
port will be provided following a training needs assessment.
Control: Standard midwifery care
Women allocated to standard care will receive care as ap-
propriate from the local maternity services in line with
usual practice at the study site, across the antenatal, labour,
birth and postnatal periods. Antenatal care is provided by
different midwives working in the community, children’s
centres, and/or hospital. Some antenatal and/or intrapar-
tum and/or postpartum care is also provided in consult-
ation with medical staff as appropriate. Core hospital
midwives and/or physicians in the birth centres and/or
labour ward provide labour and birth care and midwives in
the postnatal ward provide postnatal care. Women are also
offered midwifery visits at home and in postnatal clinics in
the community following discharge from hospital by a
range of midwives. Clinical care content follows Trust hos-
pital guidelines. Midwives in the standard care arm do not
have a linked obstetrician working directly with them and
they may have to contact on-call obstetric registrars, ob-
stetricians or other services (e.g. antenatal clinics, day as-
sessment unit) to discuss any clinical concerns, issues or
queries or make referrals.
Intervention and control: Obstetric care pathway
In accordance with the hospital guidelines, women identi-
fied as being at increased risk of PTB in both trial arms are
seen by a consultant obstetrician as soon as possible after
their nuchal scan to discuss an individual care plan based
on their obstetric and medical history. Women in both trial
arms with specific risk factors for PTB are then followed
up weekly or 2-weekly from 14 to 24 weeks’ gestation in
the cervical scan clinic, as considered necessary. Depending
on risk factors, women may be referred to a consultant ob-
stetrician and/or offered additional tests (e.g. a transvaginal
scan, a urine test and/or a vaginal swab, a fetal fibronectin
test) and other preterm interventions according to Trust
guidelines (e.g. cervical cerclage, antibiotics, progesterone,
steroids) with follow-up appointments in the clinic up to
30 weeks of pregnancy.
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Outcomes and measures
Primary outcomes
The composite primary outcome is the initiation of
any of the following interventions appropriately pro-
vided for the prevention and/or management of pre-
term labour and birth (antibiotics for urinary tract
infections, smoking cessation and domestic violence
advocacy referrals, transvaginal scan assessments of
the cervix, fetal fibronectin assessments, cerclage
insertion, progesterone administration, corticosteroid
administration, magnesium sulphate administration,
admission for observation and in utero transfer). A
composite outcome is chosen, as the primary out-
come as powering a pilot trial for PTB alone would
require too large a sample size, and helps the investi-
gators to avoid an arbitrary choice between several
important outcomes that refer to the same disease
process [25]. We will report the effect of the
Fig. 3 Flow diagram of participants
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continuity of care model on both the composite and
its components for all woman in the study, specifying
if (1) an intervention was required and (2) the inter-
vention was provided. Women who experience any
one of the intervention components will be consid-
ered to have experienced the composite outcome.
Secondary outcomes
The secondary outcomes are related to recruitment and
attrition rates; acceptability to women, health care profes-
sionals and stakeholders; health in pregnancy and other
complications; labour and birth outcomes; maternal and
neonatal postnatal outcomes; assessment of psycho-social
health; quality of care and women’s experiences of trust,
stress, system responsiveness and safety. Measures of
implementation outcomes (acceptability, adoption, reach,
fidelity, appropriateness, penetration, costs, resource use
and sustainability) will be guided by the RE-AIM
Framework [16].
Data collection
Demography, medical history and current pregnancy
health information and psycho-social health data will be
collected prior to randomisation at baseline visit (recruit-
ment). Follow-up data will continue up to 6–8 weeks post-
partum for mothers and until discharge from neonatal
intensive care unit (NICU) for babies (up to 3months).
Pregnancy outcome, birth and neonatal data will be col-
lected from maternal and infant medical records and NHS
electronic data systems. Data from validated question-
naires at baseline and postnatally (e.g. Prenatal Distress
Questionnaire [26], Everyday Discrimination Scale [27],
PHQ1 Mental Health [28], PROMIS-10 Health Related
Quality of Life [28], Labour Agentry Scale [29],
Mother-to-Infant Bonding Scale [28, 30], Trust in Nurses
Scale [31], Social Support [32]) will be used to assess
health and wellbeing, and measure women’s experiences,
continuity, quality of care and safety. Data will be anon-
ymised and entered onto the secure, password-protected
MedSciNet™.
Withdrawal
Participants can withdraw at any point without giving a
reason. Women may be withdrawn from the trial if
midwifery specialist care is required (e.g. mental health
support). Permission will be sought to access routinely
collected clinical pregnancy outcome data.
Process and implementation evaluation
The process and implementation evaluation will aim to
understand variations in the impact of the intervention on
outcomes of interest and to contextualise findings. Activ-
ity data will be integrated with planned process evalua-
tions using both quantitative and qualitative methods. We
will interview 30 women in both intervention and control
groups to assess acceptability and explore experience.
Sampling for interviews will be based on maximum diver-
sity in relation to age, socio-demographic characteristics,
parity and obstetric history. Trial recruitment and reten-
tion will be assessed by examining eligibility, participation
and attrition rates. Fidelity will be assessed through rou-
tine monthly audits and include access to care, complete-
ness of antenatal care, content of the intervention,
continuity of care (number of midwives seen), referrals.
Up to 20 key stakeholders including midwives, clinicians,
managers and commissioners will be interviewed regard-
ing acceptability of working in a new model of care and
the impact on the wider organisation.
Data analysis
Sample size calculation
There is no pre-existing precise data for the composite
outcome that we plan to use. However, we consider that a
15% increase in the rate of appropriate interventions is
both feasible and clinically useful. With six WTE mid-
wives in the POPPIE team, we can randomise 175–210
women to the active intervention (35 bookings per year
per midwife) during a 12-month period. The standard care
arm is limited by the total number of women available,
which is likely to be less than 400 per year. With 175
women in each arm (350 in total), we would have 80%
power to detect a 15% increase in the rate of appropriate
interventions (from 40 to 55%) (calculated using the Stata
version 14.2 (StataCorp, College Station, TX, USA)).
Proposed statistical analysis
The analysis will be ‘intention to treat’, including with-
drawals and losses to follow-up. Randomisation should
ensure that the groups are similar or equivalent in their
baseline characteristics; additional multivariate analysis
will be used if baseline differences are noted between
the two groups.
The relative risks (with 95% confidence intervals) of the
component primary outcomes will be calculated. Secondary
outcome measures of categorical data will be analysed with
χ2 tests and continuous data will be analysed with t tests
(for normally distributed data). Ranked or Likert-scale data
will be analysed using cumulative odds ratios. Logistic
regression and multiple linear regressions will be used if
necessary to adjust for any other confounding variables.
Outcome assessments and analysis will be blinded.
Health economic analysis
For the primary analysis, the resource use data related to
health care services utilised by the trial participants,
such as antenatal, intrapartum, neonatal care and post-
natal visits, hospital overnight stays and readmission,
will be considered. These data will be collected for both
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intervention and control arm from clinical records and
the postnatal survey.
Unit cost estimates will be applied to resource use data
to generate individual-level cost estimates. Sources of unit
costs will include routine or published literature such as
the latest NHS Reference Costs. In addition, published
sources and information from local health care providers
will be sought. For the non-health related resources, unit
costs will be sought from the relevant sources such as gov-
ernmental websites. Standard statistical methods for analys-
ing trial-based economic data will be used to evaluate the
resource and cost-impacts of the continuity of care model
compared to standard practice. We will adopt a ‘cost-con-
sequences’ approach and consider the estimated cost
impacts alongside evidence from the effectiveness study on
the impact of the continuity of care approach on wider
clinical outcomes. Results will be subject to sensitivity
analysis.
Trial management and oversight arrangements
The trial will be co-ordinated by the Trial Management
Group (TMG) which comprises the Co-ordinating
Centre staff, co-applicants and site principal investigator
(PI). The Co-ordinating Centre at King’s College London
will take responsibility for all aspects of the study includ-
ing ethical, regulatory, study conduction, data quality
and management and publication strategy. The trial
manager and designated members of the study team will
manage and monitor data, and report to the chief inves-
tigator (CI). A delegation list will be prepared for the
local site, detailing the delegated responsibilities of each
member of staff working on the trial. The local PI will
have overall responsibility for the study at the site. A
Trial Steering Committee (TSC), composed of independ-
ent members (i.e. a consultant obstetrician and gynae-
cologist; a reader in midwifery/consultant midwife; a
professor in paediatrics and neonatal medicine), has also
been established to oversee and review the progress of
the trial every 6 months. Since this is not a Clinical Trial
of an Investigational Medicinal Product, no formal data
monitoring committee or interim analysis are required
to oversee the safety of subjects in the trial. The TSC will
take overall responsibility for the conduct of the trial.
Plans are in place for detecting, evaluating and reporting
serious adverse events including safety and progress report-
ing. All study staff will have evidence of current and on-
going Good Clinical Practice training, maintain participant
confidentiality and comply with the requirements of the
GDPR and Data Protection Act 1998 with regards to the
collection, storage, processing and disclosure of personal
information. Protocol amendments, deviations and viola-
tions must be reported, reviewed and approved with the CI
and appropriate governance and regulatory authorities (if
applicable). If a potential serious breach is identified by the
CI, PIs or delegates, the sponsor must be notified within 24
h to assess the impact of the breach on the scientific value
of the trial and take the appropriate action. The sponsor is
responsible for ensuring that proper provision has been
made for insurance or indemnity to cover their liability of
the CI and staff.
Patient and Public Involvement (PPI)
Patients and the public were formally involved in the
development of the research question and outcome
measures, conduct of the study and dissemination. The
research question was developed with staff in the De-
partment of Public Health and NHS Clinical Commis-
sioning group in the borough hosting the hospital. We
used several strategies for PPI including the discussion of
the project and outcome measures important to women
and partners in workshops with NIHR South East London
PPI event, NIHR Maternity Voices Partnership (MVP)
Facebook Group, three locally convened focus groups of
Lewisham parents of preterm babies (including fathers) and
other events with service-user organisation representatives
and charities (e.g. National Childbirth Trust; Tommy’s char-
ity). A lay representative (a service user researcher and PPI
lead for maternity services) attends the TSC group. The re-
sults will also be disseminated to study participants through
individual feedback, organisational newsletter and a feed-
back event organised with our NIHR CLAHRC South
London MVP.
Discussion
The underlying reasons why midwife continuity of care
models are associated with a reduction in fetal loss and
fewer PTBs are currently unclear [6]. Little is known about
the effects of midwife continuity models of care on mothers’
and babies’ health and wellbeing during and beyond the
postpartum period; about the extent to which women feel
differently or similarly with different models of care; and
about how well these models of care are implemented in
health services. Challenges to implementation and scale-up
include midwives’ reluctance to change working patterns,
midwife concerns about burnout and exploitation, managers
concerns about cost, organisational disruption and how to
manage change, and what populations to target when whole
service change is not possible [20].
This will be the first study to provide direct evidence re-
garding effectiveness-implementation of a midwifery con-
tinuity of care model to improve clinical and processes
outcomes in pregnant women at high risk of PTB and de-
termine the feasibility of moving to a full-scale multi-centre
trial. Two Cochrane reviews [6, 33] emphasised the need
for such a research project as evaluation of these continuity
models remains a global research priority to improve the
quality of care for every woman and every child [34].
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Trial status
Ongoing. Recruitment and randomisation of participants
in the pilot trial started on 11 May 2017 and ended on 30
September 2018. Recruitment of participants for qualita-
tive interviews is expected to end on 30 March 2019.
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